Marsh & McLennan Companies Q1 2024 Earnings Call Transcript

AlphaStreet
Provided by AlphaStreet
April 18, 2024
Skip to Questions & Answers
Operator

Welcome to Marsh McLennan's earnings conference call. Today's call is being recorded. First quarter 2024 financial results and supplemental information were issued earlier this morning. They are available on the company's website at marshmclennan.com. Please note that remarks made today may include forward-looking statements. Forward-looking statements are subject to risks and uncertainties and a variety of factors may cause actual results to differ materially from those contemplated by such statements.

For a more detailed discussion of those factors, please refer to our earnings release for this quarter into our most recent SEC filings, including our most recent form 10-K, all of which are available on the Marsh McLennan website. During the call today we may also discuss certain non-GAAP financial measures for a reconciliation of these measures to the most closely comparable GAAP measures. Please refer to the schedule in today's earnings release. [Operator Instructions] I will now turn this over to John Doyle, president and CEO of Marsh McLennan.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Good morning. Thank you for joining us to discuss our first quarter results reported earlier today. I'm John Doyle, president and CEO of Marsh McLennan. On the call with me is Mark McGivney, our CFO; and the CEOs of our businesses. Martin South of Marsh; Dean Klisura of Guy Carpenter; Nick Studer of Oliver Wyman; and Pat Tomlinson of Mercer, who is joining us -- joining this call for the first time. Welcome, Pat. Also with us today is Sarah DeWitt, head of investor relations.

Marsh McLennan had a strong start to 2024. Our first quarter results were excellent and we are well-positioned for another good year. Top line continued with 9% underlying revenue growth, which was on top of 9% growth in the first quarter of last year, all of our businesses had strong revenue growth with Marsh, Mercer, and Oliver Wyman accelerating growth from the fourth quarter. We grew adjusted operating income by 11% from a year ago. Our adjusted operating margin expanded 80 basis points compared to the first quarter of 2023. We had adjusted EPS growth of 14% and we completed $300 million of share repurchases in the quarter.

In addition, we continued to add to our talent, capabilities, and scale through acquisitions. These investments will help strengthen our strategic position and sustain topline growth. For example, Mercer completed the purchase of Vanguard's OCIO business which expands our reach into the endowments and foundation segment. MMA acquired two leading agencies in Louisiana and Oliver Wyman enclosed the acquisition of SeaTec, which extends our capabilities in the aviation, transportation, and defense industries. At Marsh McLennan, we bring together specialized capabilities and perspectives across risk, strategy, and people to help clients make critical decisions with confidence.

For example, in the area of supply chain risk, we developed a solution called [Indecipherable], which draws on the perspective and capabilities of Marsh and Oliver Wyman to identify key risks in our client supply chains. Using this framework, we create a digital twin model of a client supply lines which provides for a scenario-based vulnerability assessment to help manage risk. This product is already helping clients across multiple sectors, including in the banking, manufacturing, aviation, and defense industries.

As we noted last quarter, Marsh, Oliver Wyman, and Guy Carpenter developed a unity facility, a public private insurance solution that enables grain shipments from Ukrainian ports. In the first quarter we worked with the Ukrainian government, DZ Bank, Lloyds and others to expand the facility to all ships carrying nonmilitary Cargo. This will help support Ukraine's economic resilience in time of war. In the healthcare sector Marsh and Mercer are working together to help clients evaluate connections between talent retention, patient safety, and the cost of malpractice insurance. Marsh's risk assessment capabilities and Mercer's extensive health and human capital expertise, combined with our rich data sets, are creating new, highly valued perspectives in the healthcare sector.

These are just a few examples of how we're applying our unique expertise to address pressing challenges and deliver significant value to clients. Recently, we released our annual ESG report. The report includes enhanced disclosure on our ESG efforts and underscores how the actions we're taking and on behalf of our clients also have a positive impact on the communities where we live and work. Let me share some examples. We collaborated with the center for NYC Neighborhoods to launch a community-based catastrophe insurance program. This parametric insurance program helps finance emergency grants to community members following an event, with funds reaching households within days of a catastrophe.

In cyber, we developed a global personal micro insurance solution to protect against threats like online identity theft, viruses, cyberbullying, and failure to deliver purchase goods. With regard to sustainability, we are supporting the Dubai energy and water authorities commitment to provide 100% of its energy from clean sources by 2050. As part of this work, we conducted a climate resilience assessment of one of the world's largest solar parks. We modeled the site's ability to withstand future climate conditions and proposed adaptation measures to mitigate extreme risks. We continue to improve sustainability in our own operations as well.

For example. In 2023, we expanded the use of renewable electricity across our US offices and in our largest UK locations and we submitted our climate targets for validation as part of our goal to achieve net zero globally by 2050. We remain committed to generating exceptional financial performance and returns for shareholders and we also recognize that the successful outcomes we help enable for our clients and our own actions can have a lasting, positive effect on communities around the world. Shifting to the macro picture, we see significant opportunity that helps clients navigate the range of outcomes driven by a more complex environment.

The geopolitical backdrop remains unsettled. With multiple major wars and rising tensions globally. More than half the world's population will go to elections in 2024 and the economic outlook remains uncertain as well. Despite this uncertainty, the environment is supportive of growth in our business. In general, we see continued economic growth in most of our major markets. Inflation and interest rates remain elevated. Labor markets are tight. The cost of risk is up and healthcare costs continue to rise. We have a strong record of performance across economic cycles due to the resilience of our business and demand for our advice and solutions.

Turning to insurance and reinsurance market conditions. Primary insurance rates increased with the Marsh global insurance market index up 1% overall in the quarter. Property rates increased 3% versus 6% in the fourth quarter. Casualty was up 3%, in line with last quarter. Workers' compensation decreased mid-single digits while financial and professional liability rates were down 7% and cyber pricing decreased 6%. Reinsurance market conditions remained stable. With increased client demand and adequate capacity. In the April renewal period, US property cat reinsurance rates were flat, with some decreases for accounts without losses.

Loss impacted accounts averaged increases in the 10% to 20% range. The US casualty reinsurance market was challenging, but rates were in line with January renewals. In January, April 1 property cat rates overall were down slightly on a risk-adjusted basis. Early signs for June 1 Florida cat risk renewals point to improved market conditions for seasons. Increased reinsurance appetite for growth should be adequate to meet higher demand. As always, we are helping our clients navigate these dynamic market conditions.

Now let me turn briefly to our first quarter financial performance, which Mark will cover in detail. We generated adjusted EPS of $2.89, which is up 14% versus a year ago. Revenue grew 9% on an underlying basis, with 9% growth in both RIS and in consulting. Marsh was up 8%. Guy Carpenter grew 8%, Mercer 6%, and Oliver Wyman was up 13%. Overall in the first quarter, we had adjusted operating income growth of 11%, and our adjusted operating margin expanded 80 basis points year-over-year. Turning to our outlook, we are very well-positioned for another good year in 2024. We continued to expect mid-single digit or better underlying revenue growth, another year of margin expansion, and strong growth and adjusted EPS.

Our outlook assumes current macro conditions persist. However, meaningful uncertainty remains and the economic backdrop could be materially different than our assumptions. In summary, the first quarter was a great start to the year for Marsh McLennan. Our business delivered strong performance, and we continued to execute well on our strategic initiatives. I'm proud of the focus and determination of our colleagues and the value they deliver to our clients and shareholders.

With that, let me turn it over to Mark for a more detailed review of our results.

Mark McGivney
Chief Financial Officer at Marsh & McLennan Companies

Thank you, John, and good morning. Our first quarter results were outstanding and represent an excellent start to the year. We saw continued momentum and underlying growth, strong margin expansion, double-digit growth, and adjusted EPS. Our consolidated revenue increased 9% in the first quarter to $6.5 billion. The underlying growth of 9%. Operating income was $1.9 billion and adjusted operating income increased 11% to $2 billion. Our adjusted operating margin increased 80 basis points to 32%, and we expect higher margin expansion for the rest of the year, particularly in the second half.

GAAP EPS was $2.82 and adjusted EPS was $2.89, up 14%[Phonetic] last year. Looking at risk and insurance services. First quarter revenue was $4.3 billion, up 9% compared with a year ago on both a reported and underlying basis. This result marks the 12th consecutive quarter of 8% or higher underlying growth in RIS and continues the best stretch of growth in two decades. RIS operating income was $1.6 billion in the first quarter. Adjusted operating income was also $1.6 billion, up 11% over last year and our adjusted operating margin expanded 50 basis points to 39.1%. At Marsh, revenue in the quarter increased 9% to $3 billion, or 8% on an underlying basis. This comes on top of 9% growth in the first quarter of last year.

In US and Canada, underlying growth was 8% for the quarter, reflecting solid renewal and new business growth. In international underlying growth was strong at 8% and comes on top of 10% in the first quarter last year. EMEA was up 9%, Latin America grew 8%, and Asia Pacific was up 6%. Guy Carpenter's revenue was $1.1 billion up 7% or 8% on an underlying basis, driven by growth across most regions and global specialties. This was the fifth straight quarter of 8% or higher underlying growth at Guy Carpenter. In the consulting segment, first quarter revenue was $2.2 billion, up 9% on an underlying basis. Consulting operating income was $432 million and adjusted operating income was $444 million up 9%.

Our adjusted operating margin in consulting was 20.7% in the first quarter, an increase of 40 basis points. Mercer's revenue was $1.4 billion in the quarter, up 6% on an underlying basis. This was Mercer's 12th straight quarter of 5% or higher underlying growth and continues the best run of growth in 15 years. Health underlying growth was 10% and reflected strong momentum across all regions. Wealth grew 5%, driven by growth in both investment management and DB consulting. Our assets under management were $489 billion at the end of the first quarter, up 17% sequentially and up 38% compared to the first quarter of last year.

Year-over-year growth was driven by our transactions with Westpac and Vanguard, rebounded capital markets, and positive net flows. Career revenue increased 1%, reflecting a tough comparison to a period of strong growth last year as well as softness in the US. Oliver Wyman's revenue in first quarter was $789 million up 13% on an underlying basis from the slow start we had in the first quarter of last year and reflected strength across all regions. Foreign exchange had very little impact on earnings in the first quarter. Assuming exchange rates remain at current levels, we expect FX to be a $0.02 headwind in the second quarter and a further $0.01 headwind in the second half.

Total noteworthy items in the quarter were $49 million. The majority of these items were restructuring costs, mostly related to the program we began in the fourth quarter of 2022. Our other net benefit credit was $67 million in the quarter. For the full year we expect our other net benefit credit will be approximately $265 million. Interest expense in the first quarter was $159 million up from $136 million in the first quarter of 2023, reflecting higher levels of debt and higher interest rates. Based on our current forecast, we expect $158 million of interest expense in the second quarter and approximately $620 million for the full year.

Our adjusted effective tax rate in the first quarter was 23.9%, compared with 25% in the first quarter of last year. Our tax rate benefited from favorable discrete items, the largest of which was the accounting for share based compensation similar to a year ago. Excluding discrete items our adjusted effective tax rate was approximately 26.5%. When we give forward guidance around our tax rate, we do not project discrete items which can be positive or negative? Based on the current environment, we continue to expect an adjusted effective tax rate of between 25.5% and 26.5% for 2024.

Turning to capital management, our balance sheet we ended the quarter with total debt of $13.5 billion. Our next scheduled debt maturity is in the second quarter, when $600 million of senior notes mature. Our cash position at the end of the first quarter was $1.5 billion. Uses of cash in the quarter totaled $1 billion and included $354 million for dividends $347 million for acquisitions and $300 million for share repurchases. We continue to expect to deploy approximately $4.5 billion of capital in 2024 across dividends, acquisitions, and share repurchases. The ultimate level of share repurchase will depend on how our M&A pipeline develops.

While there continues to be uncertainty in the outlook for the global economy, we feel good about the momentum in our business and the current environment remains supportive of growth. Overall, our strong start leaves us well-positioned for another good year in 2024. Based on our outlook today for the full year, we continue to expect mid-single digit or better underlying growth. Margin expansion and strong growth in adjusted EPS. With that, I'm happy to turn it back to John.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Thank you, Mark. Andrew, we are ready to begin Q&A.

Skip to Participants
Operator

Certainly. [Operator Instructions] One moment, please for our first question. The first question comes from the line of David Motemaden with Evercore ISI.

David Motemaden
Analyst at Evercore ISI

Hi. Thanks. Good morning. My first question is just on the Marsh growth. John, I caught what you said on the global pricing index, which moved down or decelerated a little bit to 1% from 2% last quarter. But the Marsh organic growth accelerated to 8% this quarter from 6% last quarter, so I'm hoping you can help me bridge the gap between accelerating growth and the decelerating pricing?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Thanks, David, for the question and good morning. We work very hard not to be an index on P&C pricing, right? It's an element, it's a macro factor that obviously does have some impact. But less than half of Marsh's revenue is exposed to P&C pricing. What I would also say to you is that where we're most exposed to commission is in the middle-market. Our index skews to larger account data and pricing is up a bit more in the middle-market than it is in the large account segment, and typically is less cyclical than what you see in the large account market. But I want to just talk about growth overall.

I was very pleased with the start to the year, 9% on top of 9% last year and accelerated growth from the fourth quarter of 7%, as I mentioned. Marsh, Mercer, and Oliver Wyman all had accelerated growth from the fourth quarter. The macros continue to be supportive, David. Solid GDP growth in most major markets, although it's under a bit of pressure. Inflation and interest rates remain elevated. There's tight labor markets, as I said before, rising healthcare cost. The overall cost of risk continues to increase and demand remains very strong. Not long out of the pandemic, of course, we've got a couple of global wars happening, supply chain stress. Our clients are showing broader risk awareness.

We're talking to them about that and really trying to help them find better balance between resilience and efficiency and we continue to invest through this cycle, right. I talked about a couple of the acquisitions we did. We're improving our mix of business as well. We sold some admin businesses at Mercer in the quarter and I'm very, very pleased with how our colleagues are executing too. We've been working on our client engagement model and improving that, continue to invest in sales operations and as I've talked about, over the course of the last year, we're collaborating more than ever. It starts with the talent that we have. We have the best talent in the markets that we operate in. We're, of course, not immune to macros, including pricing on some level, but we're a resilient business and we're quite excited about 2024. Do you have a follow-up?

David Motemaden
Analyst at Evercore ISI

I do, and thanks for that answer. That's helpful. I guess, just specifically zeroing in on the US and Canada within Marsh, that had a nice acceleration in the quarter. Could you talk about the drivers specifically for that business? Was it middle-market, was it your capital markets activity coming back and sort of your outlook on the sustainability, further recovery and growth there?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Sure, sure. Yes, Marsh in the US got off to a terrific start. US and Canada, I would point out. Martin, maybe you could give David a little bit more color.

Martin South
President & CEO, Marsh at Marsh & McLennan Companies

Yeah, it wasn't just the US and Canada, it was great balanced growth across the business. But I'll dig into the US a little bit and give you some color on some of the drivers of growth there and it's really been a product of a lot of work in the last few years to get where we are. So the overall growth of 8%, our businesses -- the mid-market business, MMA, had a terrific start to the year. The growth in that business is driven both by renewal and fantastic new business. Victor, our MGA business, rebounded, has a great performance, very strong performance in Canada. [Indecipherable] had a tough year last year, it bounced back and the core business in the US grew nicely. So very good.

The drivers really, particularly in the specialty areas, construction was very strong in the first quarter. Our MMB business was strong. Our advisory business in the US was very strong as part of the risk advisor of the future to the tip of the spear and makes our relationship much stickier. So our renewal growth was good and our loss business rate was down. So we feel very good about all the areas that we've been focusing on, about client relationship, specialization, industry focus advisory, all these things are the drivers for growth. So we feel -- we feel very good about things.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Thanks, Martin. David, I would add, it wasn't a bang-out quarter in terms of M&A activity in our transaction risk business, but it's a smaller part of our -- smaller part of our business now. Just a little feedback there. It's a smaller part of our business after the slowdown. So the impact was less. But we did see some volume in M&A activity pick up during the quarter, which of course is encouraging. So thank you for your questions. Andrew, next question, please?

Operator

Certainly. Our next question comes from the line of Jimmy Bhullar with J.P. Morgan. Please go-ahead.

Jimmy Bhullar
Analyst at J.P. Morgan

Good morning. So I was wondering if you could just elaborate on the comments John had on the reinsurance market. And it seems like things -- the market is less tight than it was over the past year. But what are you seeing in terms of buyer behavior? Are cedents[Phonetic] trying to buy more, given that pricing has come in a little bit, or are they trying to save money and keep sort of coverage levels consistent with what they've had in the past year?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Sure, Jimmy. Thanks for the question. Maybe I'll elaborate a little bit on some of my prepared remarks and then ask Dean to talk a bit about the reinsurance market. But I think both markets continue to stabilize on average in the quarter. And again, I would remind everyone it's a collection of markets, not a single market. That stabilization is good for our clients and in some cases, a better market has led to increased demand in both insurance and reinsurance. I would also point out that in recent years, we've had higher premium growth in the captives that we manage at Marsh compared to the premium flow into the traditional market. That may change a bit now, we'll see as markets stabilize and our clients can adjust to what the market looks like going forward.

I mentioned earlier our index skews to major accounts. So pricing in the middle-market continues to move up a bit more than the data points I mentioned earlier. But I would also say that insurers and reinsurers are cautious about that rising cost-of-risk environment that I mentioned as well. And so, while again, a stabilizing market is better for our clients overall, I don't expect that relative stability to change anytime soon given some of the rising cost of risk issues that the insurance community is confronting. So Dean, maybe you can talk a little bit more about what's happening in reinsurance.

Dean Klisura
President & CEO, Guy Carpenter at Marsh & McLennan Companies

Yeah. Thanks, John. And Jimmy, I'll give you a little bit more color on the April 1 reinsurance renewal, that would be helpful. As John noted, we saw a continuation of market conditions that we experienced at January 1. And as John noted, market conditions are stable, but we're definitely seeing increased client demand to provide additional property cat limit, particularly at the top end of programs. That was very pronounced throughout the first quarter at 1/1 through the quarter and certainly that trend continued on April 1. Strong capital inflows into the reinsurance market, driven by strong reinsurer returns -- double-digit returns in 2023.

We talked about last quarter on the call, reinsurer appetite has increased for property cat. There is an inflow of capital and capacity. Competition at the top end of programs, it's been good for both buyers and sellers in the marketplace. Specifically to property cat, in the US, at April 1, as I said, capacity was strong. As John noted, the market was generally flat to down incrementally for clients without cat losses. Accounts with cat losses saw 10% to 20% kind of rate increases. But keep in mind, we give you rate-adjusted figures. But when you factor in inflation, exposure growth, value growth, premiums on these cat programs are still increasing year-over-year. It continues to be a tailwind for Guy Carpenter in the marketplace and as I said, there's a lot of competition for cat business.

US casualty, as John noted, was challenging, just as challenging on April 1 as it was at the January 1 renewal. Reinsurers are exerting pressure on pricing in terms and conditions. Ceding commissions are facing downward pressure from reinsurers on certain quota-share contracts, particularly financial lines, which Martin has talked about in the past. Excess-of-loss contracts are seeing rate increases across the board, in some cases, double-digit. However, there was adequate casualty capacity in the marketplace at April 1, and all of the programs that we placed got completed in full. But I would balance that against continued reinsurer concern with the adverse development, driven by social inflation and increasing loss cost trends.

I think that's a good summary of where we were in the US market. Just a note on Japan, big April 1 cat date in Japan, a very orderly market, sufficient capacity, many cat programs were oversubscribed. We didn't observe any structural changes. Attachment points stayed where they were from a year ago and again, it was a market that was down on average 5% from a rating perspective, and we didn't really observe any rate impact from the January earthquake in Japan. Overall, a very orderly market at April 1 in Japan.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Terrific, Dean. Thank you. Jimmy, do you have a follow-up?

Jimmy Bhullar
Analyst at J.P. Morgan

[Indecipherable] income, it was flat sequentially and lower than 3Q. I'm assuming that's more seasonality, but if you could just talk about your expectation for that given where short-term rates are currently?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Mark, you want to jump on that one?

Mark McGivney
Chief Financial Officer at Marsh & McLennan Companies

Yeah, Jimmy. There is a little season[Phonetic] as you pointed out. There is a little -- tends to be a little seasonality in our fiduciary balances. Q1 and Q4 tend to be seasonal lows modestly. So that would explain that. In terms of outlook, we'll see what happens to the rate environment. The interest -- our fiduciary interest income is going to be a function of balances in rates, and we've got about $11.5 billion of balances. So depending on what you want to assume for the trajectory of rates, the math is pretty straightforward.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Thank you, Mark. And thank you, Jimmy. Andrew, next question, please.

Operator

And our next question comes from the line of Elyse Greenspan with Wells Fargo.

Elyse Greenspan
Analyst at Wells Fargo & Company

Thanks. Good morning. My first question was on the margin guidance. You guys said more margin expansion in the back half of the year. What's driving that? Is there just more investment in the first half, more savings falling in the second half, or something else that's driving the seasonality within the margin expansion this year?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Good morning, Elyse. We expect again good margin expansion in 2024. As you pointed out, Mark noted, we expect the second half to be better than the first half. We have some expected headwinds, not really seasonality, but really driven from a higher [Indecipherable] a year ago, some acquisition-related costs, and some higher reimbursable expenses. But I want to remind everybody not to focus on any one particular quarter. Again, margin is an outcome of really how we run the business, and it's not a primary objective of ours. Again, having said that, we see opportunity for margin improvement, continued margin improvement. But we're going to continue to make attractive investments to support the medium to long-term growth of the business.

We have a number of different efforts underway, ongoing workflow and automation efforts at Marsh, Mercer and Guy Carpenter. And we continue to press for opportunities to improve efficiency at the intersections of our businesses as well. So we see opportunity and as we pointed out, we expect the second half to be better than the first. Do you have a follow-up, Elyse?

Elyse Greenspan
Analyst at Wells Fargo & Company

Yes, thanks. And then my second question on Marsh recently launched its wholesale venture Victor Access. I know it's early days, but what was the impetus for this strategy? And is there any reason why the majority of the wholesale risk currently placed by Marsh with third-party wholesalers couldn't potentially be internalized through Victor over time?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

So let me be clear, Elyse, we're not looking to build a third-party wholesale business. There's obviously been considerable growth in the wholesaler to E&S market over the course of the last several years. We want to bring the best solutions in the marketplace to our clients. Generally, we're preferring admitted solutions for our clients. Not that there aren't good things that happen in the E&S market. Of course, there are and innovation is one of the areas where the E&S market is important. But we want to access as much of that E&S market directly.

We actually access most of our E&S market solutions directly today. But we want to continue to press and make sure that we can access as much of that market directly. So it's client-driven, It's about us managing the client outcomes, client experiences, really as directly as possible. Having said that, we'll continue to use wholesalers for niche expertise. They serve us very well and our clients very well. In those cases, they also have strong program businesses as well. So anyway, that's what it's about. It's just, again, making sure we can directly access as much capital directly as possible for our clients. Thank you for that. Andrew, next question?

Operator

Our next question comes from the line of Greg Peters with Raymond James.

Gregory Peters
Analyst at Raymond James

Good morning, everyone. I'd like to pivot to -- for the first question, pivot to the Consulting business, which had a nice quarter. I'm wondering if you can provide some additional color around how the different pieces are moving. I know some of the management consultants have pre-announced that they're going to be cutting staff this year. I'm not really seeing any signs of weakness in your pipeline, but maybe you could give us some color because forecasting this out seems to be a little bit of a black box.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Okay. Thanks, Greg. Yeah, we are very pleased with the start to the year. As you recall, of course, Oliver Wyman had a slow start to the year in 2023, had a nice year overall of growth. There's going to be a bit more volatility to revenue growth at Oliver Wyman, but we also expect better growth on average from Oliver Wyman over the medium to longer term. Nick, maybe you can share with Greg some color on demand in the first quarter.

Nick Studer
President & CEO, Oliver Wyman Group at Marsh & McLennan Companies

Thank you, John, and thank you, Greg. Yeah, 13% was a very pleasing start to the year, it makes a marvelous headline, and we're very, very proud of a good start on what, as you noted, is a tough environment for many in our profession. John has already given the caution about taking the two-year view. We also probably benefited from a few little timing benefits of things that might have shown up in Q2, might have shown up in Q1 and we still very much give guidance through the cycle. This should be a mid-to-high single-digit business and you noted the sort of forecasting it out is a tricky challenge. That is true because we have a relatively short backlog.

The nature of our work is such that when clients need assistance, they need it quickly. And so we are always ready to move very, very nimbly.

To give you a little bit more color, we grew pretty strongly across all the four regions of our management consulting business and our economic research business, NERA, also grew very strongly, fastest in the Middle East, but in the double-digits or very close to double-digits in all three of the other major regions we have. And sectorally it was also fairly broadly spread. Our communications media and technology team grew well, healthcare grew well, banking seeing a rebound in private capital work, which I've noted on previous calls, has been pretty robust even in the face of obviously a very much lower deal market, but our work on portfolio company performance has helped us there.

But insurance also growing, and quite broadly across the capabilities that we bring to that[Phonetic] as well. So we think we're in a good position. We're very confident we gained share over the last few years, but it's a tough consulting environment and our pipeline indicates that mid-to-high single-digit growth environment, growth forecast, is how we think about this business through the cycle.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Thank you, Nick. That's very helpful. And Greg, maybe I'll ask Pat Tomlinson also to share some thoughts just on the first quarter at Mercer, given our consulting operations there. And Pat, while you have the floor, as I mentioned, obviously, you're joining this call for the first time. Maybe you could talk a bit about your priorities at Mercer.

Pat Tomlinson
President of Mercer at Marsh & McLennan Companies

Sure. Thanks, John. Yes, we are pleased with our Q1 2024 underlying growth, as mentioned earlier, of 6%. It was our 12th consecutive quarter with 5% or more growth, especially the breadth across the practices. Health, another impressive quarter with 10% growth in Q1. That growth was [Technical issue] double-digit growth nearly across all regions and it comes on the back of investments in hiring new talent, focus on thought leadership, creating digital tools and really focusing in on client segmentation, trying to match client healthcare needs, based upon industry segment size with the innovative and adaptive solutions that we have. So really trying to meet clients where they are.

We certainly benefited from strong retention. We had good renewal growth. Insurer revenue and medical cost inflation has an impact there. We see significant demand for digital solutions and the innovative benefits that are kind of underscoring the value that we're providing to clients. If I pivot over to wealth, we grew 5% in Q1. There was good balanced, equally strong performance in DB&A and IMS. We see DB plans funding statuses continue to benefit from elevated interest rates that's driving an increase in risk transfer over the last couple of years, as well as we have some regulatory requirements and demands that are creating some project work.

If you add in some capital -- some volatile capital markets, it's driving strong demand for both our actuarial and our Investment Solutions business. Speaking of Investment Solutions, in OCIO, we benefited from some transactions in Westpac and Vanguard, Mark mentioned that earlier, but also good net new inflows and capital markets provided us some revenue lift in Q1. From a career perspective, growth was muted to 1% for the quarter, but we're following a period of strong growth over the past several years, including a challenging 12% comparable last year. The growth was strong in international, is very broad across all practices and regions.

We did see, as was mentioned, some softness in US career, specifically in rewards in the transformation space, as I would say, clients are starting to navigate some of the macro conditions, right. So let me highlight the career practices coming off that very long period of high-growth. As I mentioned, double-digits in for the past eight quarters, driven in large part, I would say, by inflation and employee attrition. If we all remember the great resignation back coming out of the pandemic, which drove a lot of labor shortages and really created a lot of demand for projects with clients as they were trying to think about the rewards and how to pay people to keep them retained, the skills that they might need if they had to pivot, because they didn't have the right resources, and also starting to think about transformation as they were having less resources to work with, and there was innovation in technology, as we've all talked about AI, in the past and helping clients through those.

So certainly, I think from that perspective, we feel good that there's good breadth of our solutions and demand in the market as we go ahead and fill those needs. John quickly asked me to talk a little bit about how I think about the business and the priorities too. So obviously, my first call. On April 1, I got to step in and begin this opportunity of a lifetime leading Mercer and our 21,000 colleagues from around the world, as we are focused on creating brighter futures for our clients and for their people. I am extremely humbled and honored to be the CEO of this fantastic firm and personally, I really want to thank Martine Ferland for a very smooth transition and for the growth momentum and culture that she helped create here.

Priority-wise, I want to accelerate that momentum. From the impact that we're having to clients to the fantastic careers we build for colleagues here, the collaboration amongst our colleagues across Marsh McLennan, we can leverage new technologies, and we perform really purpose-driven work, and can have a positive impact on our communities as well. I think we're very well-positioned, as we've been repositioning ourselves over the last several years, reshaping our portfolio. Mark mentioned the divestitures. We've been divesting admin practices. We've been building capabilities and reach and global benefits in OCIO. We've been accelerating acquisitions and we're really just creating more value for clients at scale. And that's what we've been focused in on. So I'm very optimistic about our future.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Thank you, Pat. We're excited to have you at this table. Greg, do you have a follow-up?

Gregory Peters
Analyst at Raymond James

I do. Thanks for the detail on that answer. I want to pivot to M&A and specifically, Mark, I think you mentioned the interest expense outlook for the company and we note the higher interest rate cost of the debt that's being issued versus debt which is being paid off. So I'm curious if there's been any follow-through on those higher costs in the terms of valuation of transactions that you're looking at. And, I'm also curious if there's any valuation difference between larger properties versus smaller properties that you're looking at in the M&A market. Thank you.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Yeah. Thanks, Greg. What I would say is we remain quite active in the market. There's a good -- we have a good strong pipeline as I've talked about in the past, we have an excellent reputation in that marketplace as being a good owner as well. So we're excited about the deals we did in the first-quarter and again, we're going to continue to remain active in the market. I think valuations have remained stubbornly high, I would say, on the other side of things and while we might expect that for top-quality assets, I would also point out that some lesser-quality assets have traded at some very, very high multiples of late. And so we're going to be picky. We're looking for well-led businesses with real strong growth fundamentals that make us better and are a good cultural fit for our organization. We've been very successful at it. And again, as Mark pointed out, we expect to continue to deploy capital in the market going forward. Thank you, Greg. Andrew, next question, please.

Operator

And our next question comes from the line of Michael Zaremski with BMO Capital Markets.

Michael Zaremski
Analyst at BMO Capital Markets

Hey, great. Good morning. Probably for Mark on the margins and the expense buckets. If I look over the last year-plus, the margin improvements come much more so from the general and other bucket, rather than comp and ban. It looks like that it flipped a little bit that relationship this quarter, if I'm correct. Anything changing there, given the expense management programs, or just in terms of how we should think about where the margin improvement is coming from on a go-forward basis?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Thanks, Mike. Mark, do you want to.

Mark McGivney
Chief Financial Officer at Marsh & McLennan Companies

Yeah, I think it's a great point that you're making and I think it reflects the strategy of the company. We've said we continually invest in positioning ourselves for the future. And over the last several years, we've talked about the heavy investments we've made organically in talent. And so I think we've done a terrific job of really being thoughtful about all of our other operating expenses, functional costs, how we're leveraging things across the firm, T&E. Really some of the gains we made in the pandemic, we've harvested them. So as you point out, a lot of our margin expansion over the last five years has come from being really disciplined on things far away from the client and investing heavily in client-facing talent and so, I think that is a factor in our growth. And I think also as we look forward, there's going to be leverage in those investments, which is why we're optimistic about margins going forward.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Thank you, Mike.

Michael Zaremski
Analyst at BMO Capital Markets

Okay.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Do you have a follow-up?

Michael Zaremski
Analyst at BMO Capital Markets

Yeah, a quick follow-up. And I know you gave a lot of commentary on kind of commercial primary insurance pricing power, you told us the Marsh Index declined a bit. Just curious if you can offer any more context. 1% kind of feels like a soft market number. What is it -- are you seeing just returns on behalf of your career partners being kind of excellent that's kind of driving the pricing power downwards in light of kind of what still seems like inflationary trends, or just any more color there on kind of what's causing the decel? I know you gave us by line commentary. So I don't know if there's a lot more to add.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Yeah. Mike, I would say that, it doesn't feel like a soft market to our clients after five years of price increases. And as I noted, our index skews to larger accounts and where there's a bit more volatility, typically, throughout the cycle. I expect cycles to be shorter and narrower than what they've been in the past, right? There's better data, better technology on the underwriting front. Capital moves so much more quickly in and out. That's part of the E&S market dynamic that you all have observed over the course of the last several years. So I expect kind of more relative stability and from time to time, of course, certain areas of risk, things will change in some meaningful way and that will maybe bounce a particular product outside of a normal cycle.

Insurer and reinsurer underwriting results have improved in the aggregate over the course of the last couple of years. And I think most feel good about how their book -- how their portfolios are positioned. It's not all one result, of course. We saw some reserve additions in the fourth quarter results overall. And as I mentioned on our call in the first quarter, the great unknown is casualty loss costs, right? There's lots of emerging data that's troubling for our entire ecosystem, for our client, and it contributes to that rising cost of risk that I mentioned earlier. I maybe should also point out, and Dean touched on this a little bit that our index adjusts for limit, exposure, attachment point, and it includes new business, right.

You see some other indices that are out in the market that don't necessarily adjust for all of those factors. And then maybe the last point, Mike, that I would make is that, that number doesn't necessarily correlate directly with what premium growth is in the market, right, because at the end of the day, I mean, it might be at -- you might have less of an increase, you might have certain clients buying more. I think that's most prevalent in the reinsurance market at the moment, but we're seeing that in some cases at Marsh as well, where clients again having adjusted to the new market pricing and new market equilibrium has led to a higher level of demand for coverage from our clients. So anyway, I hope that's helpful. Andrew, next question, please.

Operator

Our next question comes from the line of Yaron Kinar with Jefferies.

Yaron Kinar
Analyst at Jefferies Financial Group

Thank you, good morning. Two questions on Marsh and the market environment you're seeing there. And I think the first one maybe ties a lot to your last comments, John. Are you surprised to see casualty rates only up 3% just given the loss trends? I guess I'd love to hear your views, both as the CEO of Marsh, but also maybe as a former underwriter.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

It's a -- actually, it's very, very hard right now, as I mentioned earlier. There's some troubling data points, right? And thrown in the mix of the last several accident years, of course, a couple of years of the impact of the pandemic, right. And so, just on the clients where we help them -- larger clients with big risk management programs that have a level of frequency, it's very, very difficult to project where loss costs are. But as I said, the underwriting community is better than it's ever been, they have better data, better technology, but there again are some troubling signs. It's not just increased frequency, it's not just kind of nuclear verdicts, that term gets kind of thrown around, or even some of the bigger settlements, there's a frequency of larger events.

You see the Francis Scott Key Bridge as an example, that will be a big loss in the market, maybe not as much a casualty loss, but a big loss in the market. But even in like commercial auto, and you've certainly seen that play out in the personal lines auto market, just kind of more frequency type events, just costing more to get resolved. And so, we're putting our efforts to helping our clients think through how to better run off liabilities that they assume and even transfer into the market and the insurers are investing quite a bit in their claims capabilities as well to try to get ahead of this. But I think we're all pointing to again some flashing yellow signals out there about the rising costs overall. Do you have a follow-up?

Yaron Kinar
Analyst at Jefferies Financial Group

Yes, I do and thanks for the color there. So in Marsh, organic, obviously, was strong and then we certainly saw a very nice result in US and Canada. I guess the only place I could maybe poke a little bit if I were to try would be Asia-Pacific, where we saw a step-down. Is that -- is there a timing issue there with some one-offs? I know you had a very, very strong 1Q '23 there, but anything you could point to in terms of the organic results in Asia-Pacific would be helpful.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Yeah. I don't -- no one-offs or major issues there, just on top of a couple of years of very, very good comps and strong growth. We love how we're positioned in Asia. Big protection gaps throughout Asia. We have really strong country -- in-country operations all throughout the region. So we're not just a regional center. We're in-country and working very, very closely with our clients there. As we've said to you in the past, I wouldn't look at any one particular quarter. And again, it's on top of what's been some outstanding growth in Asia over the last couple of years. So we feel good about where we're headed in Asia overall. Andrew, next question, please.

Operator

Certainly. One moment, please. And our next question comes from the line of Meyer Shields with KBW.

Meyer Shields
Analyst at KBW

Great, thanks. I was hoping to discuss the competitive environment in RIS, maybe from two perspectives. First, I'm wondering whether there is a difference in the market share gain potential when you're in a rising rate environment and the enormously fragmented brokerage world includes a lot of companies that just don't have the resources to help clients manage higher insurance costs as successfully as a company with Marsh's resources. How much of a difference does that make?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Yeah, it's a good question, Meyer. We're very, very focused on trying to bring scale benefits to our -- well, to all of our key stakeholders, right, including our colleagues, right? We want them -- when they work here, we want them to feel like they have nearly 90,000 folks helping support them with learning and development, data and analytics, market access that you might not have should you choose to work somewhere else in our industry. So we certainly think about it from the colleague perspective, we think about it from the client perspective and we think about it from an investor point of view as well.

What I would say from a client perspective, broadly speaking, again, this is maybe a bit more upmarket than some of the fragmented segments that you talked about before. Our clients are more risk-aware than they've been in the past. I think we have had a role to play in that, in trying to make them more risk aware of some better risks. And again, recent events have certainly helped heighten that. But it's incumbent upon us to bring those scale benefits to the market. And not just scale benefits in terms of data analytics or market access, but different types of solutions.

I mentioned earlier our captive business. We're the largest captive manager in the world, and that's been a meaningful outlet for our clients to manage risk in the rising rate environment over the course of the last several years. So, yes, scale matters. I would also tell you that it plays a role for some of the sellers in the market as well, as we talk through with potential M&A targets, why they may look to sell at the moment at times, it's regarding scale type -- scaled-up type capabilities that we have that are difficult for them to replicate. And so as I said earlier, we're looking for well-led businesses with really solid growth fundamentals, but we know we can make them better too. And that's the exciting part for us. Do you have a follow-up?

Meyer Shields
Analyst at KBW

I do, but I want to thank you for that. That was very thorough. When we look at the parts of the brokerage market that are more concentrated here, I guess, I'm thinking reinsurance or Fortune 100-type accounts, in your view, is the competitive -- are competitors fighting at full strength? Are they all -- is competition right now as intense as it normally is, or any differences from longer-term norms?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

No, it's -- I mean in both of the segments you mentioned, it is a highly competitive market and we love competition. There's nothing that gets me more fired up than getting out in front of clients and, of course, winning ultimately. And our team is the same way, we're passionate about the value that we try to deliver to our clients. And so, as I mentioned earlier, we're collaborating more than ever. And in those particular segments you mentioned, I think it's been particularly meaningful over the course of the last year or so, our efforts to bring a broader set of capabilities to that client set. But no, it's a very, very competitive market and we welcome it. It makes us better. Thanks, Meyer. Andrew, next question. Maybe the last one.

Operator

Our next question comes from the line of Robert Cox with Goldman Sachs.

Robert Cox
Analyst at The Goldman Sachs Group

Hey, thanks. In the prepared remarks, there were some comments on healthcare costs continuing to rise. I was hoping you guys could talk about what you're seeing there and maybe parts of the business, maybe, between brokerage and consulting that are generating the strongest organic growth in that 10% organic in health.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Sure. Thank you, Robert. Healthcare and the healthcare industry is a big part of our business overall. And I don't think it's any secret that medical inflation and healthcare-related cost inflation is a major pressure point for our clients in many markets, really around the world. It's been a big driver of growth for us and we continue to invest in it. I talked about, in my prepared remarks, some of the collaboration between Marsh and Mercer to try to bring some sort of relief to an angle of cost pressure in that marketplace. But Pat, maybe you could talk about the growth we're seeing and some of the cost inflation as well.

Pat Tomlinson
President of Mercer at Marsh & McLennan Companies

Sure. So, the way that healthcare inflation impacts the business varies based upon the area of the world that we're in. In certain areas of the world where predominantly fee based, it's more a large market that would predominantly be from a Mercer perspective inside like the US and some of our more mature larger markets. And then, in a lot of the markets, we are a little bit more brokerage-based to where it's based that way. But let me be clear, even the spots where we're fixed fee, healthcare inflation drives significant increased cost to clients. So, it does create a lot of -- it creates demand for work for us, a lot of project work.

So, we will see projects out of that healthcare inflation, it's not necessarily directly driven that way. And even if there's healthcare inflation in the other areas where it's brokerage, it's not a linear type activity from a commission perspective because we're -- once that cost is flowing through to the client P&L, we're always out there doing plan redesign for a client to help make sure that that full cost of healthcare inflation is not flowing through their P&L, right, because they really don't control -- that's one of the larger costs that they don't control themselves based upon the activity that they've had. So that's really where a lot of the inflation helps us. Part of it is increased activity and project work.

Occasionally it does create higher rates that flows through in brokerage, but many times those higher rates, we're still doing plan design with the client to try and mitigate the impact that is going to have on the client P&L even in a spot where it's straight commission based brokerage, we're trying to mitigate those costs.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

So, rising health and benefit costs in a tight labor market, again, is a pressure point. And another example of where, again, we can bring scale and a broader set of capabilities to the market that our clients appreciate. Do you have a follow-up, Robert?

Robert Cox
Analyst at The Goldman Sachs Group

Yeah, very helpful. Thank you. Maybe just last question. On the wealth segment, correct me if I'm wrong, but I think last year, probably, the pension business was growing stronger than your investment business. Did that occur as well in the first quarter here or were both of them kind of similar to the 5% organic growth that was achieved in well?

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

Yeah, we had good solid growth across investment management and defined benefits. As Pat mentioned, our DB business and this period of elevated interest rates have seen a bit more growth than we expected over the course of the last couple of years, but good growth in our OCIO business and our broader set of consulting capabilities inside of our investment business. So, yes, we felt good about that. Thank you, Robert. Andrew?

Operator

Thank you. I would now like to turn the call back over to John Doyle, President and CEO of Marsh & McLennan, for any closing remarks.

John Doyle
President and Chief Executive Officer at Marsh & McLennan Companies

All right. Thank you, Andrew. And I want to thank everyone for joining us on the call this morning. In closing, I want to thank our colleagues for their hard work and dedication. I also want to thank our clients for their continued support. Thank you all very much, and I look forward to speaking with you again next quarter.

Operator

[Operator Closing Remarks]

Corporate Executives
  • John Doyle
    President and Chief Executive Officer
  • Mark McGivney
    Chief Financial Officer
  • Martin South
    President & CEO, Marsh
  • Dean Klisura
    President & CEO, Guy Carpenter
  • Nick Studer
    President & CEO, Oliver Wyman Group
  • Pat Tomlinson
    President of Mercer
Analysts

Alpha Street Logo